J. Lawrence

Quantitative detection of platelet GPIIb‐IIIa receptor antagonist activity using a flow cytometric method

L. Green, J. A. Jakubowski, S. Um, 1998, Journal of clinical laboratory analysis.

Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.

H. Gralnick, H. Gralnick, S. Williams, 1990, The Journal of clinical investigation.

Pulsed laser and thermal ablation of atherosclerotic plaque: morphometrically defined surface thrombogenicity in studies using an annular perfusion chamber.

M. Leon, P. Smith, R. Bonner, 1992, Journal of the American College of Cardiology.

Platelet adherence and thrombus formation with flowing human blood on atherosclerotic plaque: reduced thrombogenicity of Watanabe-heritable hyperlipidemic rabbit aortic subendothelium.

M. Leon, L. Prevosti, W. Kramer, 1989, Thrombosis research.

Asialo-von Willebrand factor inhibits platelet adherence to human arterial subendothelium: discrepancy between ristocetin cofactor activity and primary hemostatic function

H. Gralnick, J. Lawrence, 1987 .

Asialo-von Willebrand factor inhibits platelet adherence to human arterial subendothelium: discrepancy between ristocetin cofactor activity and primary hemostatic function.

H. Gralnick, H. Gralnick, J. Lawrence, 1987, Blood.

Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: effects on platelet spreading and ultrastructure on human arterial subendothelium.

H. Gralnick, J. Lawrence, 1987, The Journal of laboratory and clinical medicine.

Whole-blood platelet aggregation predicts in vitro and in vivo primary hemostatic function in the elderly.

P. Southern, J. Morrissey, D. Leifer, 1995, Arteriosclerosis, thrombosis, and vascular biology.